secwatch.observer — SEC 8-K summary
======================================

Issuer:     Semnur Pharmaceuticals, Inc. (SMNR)
CIK:        0001913577
Form:       8-K
Filed at:   2024-08-09T23:59:59+00:00
Accession:  0001213900-24-067209
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Denali Capital extends business combination deadline to Sep 11 via $180K Scilex note
--------------------------------------------------------------------------------

- Deposited $15,036.74 into trust to extend deadline to Sep 11, 2024 from Aug 11.
- Issued up to $180,000 convertible note to Scilex (SCLX); initial draw $15,036.74.
- Note bears no interest, repayable upon business combination or liquidation; convertible at $10/share.
- Remaining $164,963.26 available for future monthly extensions as needed.
- If no business combination, note repaid only from non-trust funds or forfeited.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1913577/000121390024067209/0001213900-24-067209-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1913577/000121390024067209/ea0211006-8k425_denali.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-067209

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer